Juvenile Idiopathic Arthritis Guideline
Guideline Status
Step 10: Final guideline published and disseminated
See a list of all clinical practice guideline project steps on the Clinical Practice Guidelines page.
2021 JIA Oligoarthritis, TMJ, and sJIA Guideline
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis
Documents related to the 2021 JIA oligoarthritis, TMJ, and sJIA guideline:
JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 1 – Methods
JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 2 – Search Strategies
JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 3 – Evidence Report
JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 4 – List of Outcomes
JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 5 – Panels/Teams Involved
JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 6 – Study Selection
JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 7 – Research Agenda
JIA Oligoarthritis, TMJ, and sJIA Guideline Project Plan
JIA Oligoarthritis, TMJ, and sJIA Guideline Public Comments
JIA Oligoarthritis, TMJ, and sJIA Guideline Author Response to Public Comments
2021 JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging
Documents related to the 2021 JIA nonpharmacologic, medication monitoring, immunizations, and imaging guideline:
JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 1 – Methods
JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 2 – Search Strategies
JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 3 – Evidence Report
JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 4 – List of Outcomes
JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 5 – Panel Teams
JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 6 – Study Selection
JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 7 – Research Agenda
2019 JIA Guideline
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis
Documents related to the 2019 JIA guideline:
JIA Guideline Supplementary Appendix 1 – Methods
JIA Guideline Supplementary Appendix 2 – Panel Teams
JIA Guideline Supplementary Appendix 3 – Outcomes Framework
JIA Guideline Supplementary Appendix 4 – Search Strategies
JIA Guideline Supplementary Appendix 5 – Study Selection
JIA Guideline Supplementary Appendix 6 – Evidence Report
JIA Guideline Disclosure Summary
JIA Guideline Project Plan
JIA Guideline Public Comments
JIA Guideline Author Response to Public Comments
2019 JIA Uveitis Guideline
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis
Documents related to the 2019 JIA uveitis guideline:
JIA Uveitis Guideline Supplementary Appendix 1 – Methods
JIA Uveitis Guideline Supplementary Appendix 2 – Panel Teams
JIA Uveitis Guideline Supplementary Appendix 3 – Search Strategies
JIA Uveitis Guideline Supplementary Appendix 4 – Study Selection
JIA Uveitis Guideline Supplementary Appendix 5 – Evidence Report
JIA Uveitis Guideline Supplementary Appendix 6 – Dropped PICO Questions
JIA Uveitis Guideline Disclosure Summary
2013 JIA Guideline
2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications
Documents related to the 2013 JIA guideline:
JIA Guideline Project Plan
JIA Guideline Summary of Disclosures
JIA Guideline Public Comments
JIA Guideline Author Response to Public Comments
2011 JIA Guideline
2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features
Documents related to the 2011 JIA guideline:
Clinician’s Guide to the 2011 ACR Recommendations for the Treatment of Juvenile Idiopathic Arthritis